Transcend Capital Advisors’s GoodRx Holdings GDRX Stock Holding History

Transcend Capital Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-32,700	Closed	-$1.45M	–	502
2021 Q3	$1.45M	Hold	32,700	–	–	0.13%	171
2021 Q2	$1.18M	Sell	32,700 -15,080	-32%	-$557K	0.17%	142
2021 Q1	$1.86M	Buy	+47,780	New	+$2.15M	0.22%	113

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Transcend Capital Advisors's GDRX Position: Q4 2021 in Review

Transcend Capital Advisors sold out of GoodRx Holdings (GDRX) in Q4 2021, closing a stake of 32,700 shares — an estimated $1.45M sold.

Transcend Capital Advisors first reported a position in GDRX in Q1 2021 and held it in 3 quarters. The position peaked at $1.86M in Q1 2021. 216 funds tracked by Wall St. Rank hold GDRX as of Q4 2021.

Transcend Capital Advisors reported no remaining GoodRx Holdings position as of Q4 2021 after selling out during the quarter.
Transcend Capital Advisors sold 32,700 GoodRx Holdings shares in Q4 2021, an estimated $1.45M.
Transcend Capital Advisors first reported a position in GoodRx Holdings in Q1 2021 and held it in 3 quarters.
Transcend Capital Advisors's GoodRx Holdings position peaked at $1.86M in Q1 2021.
216 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2021.

Based on Transcend Capital Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.